Lamellar body counts on gastric aspirates for prediction of respiratory distress syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 100, Issue 2, 2011, Pages 175-180

  Verder, H ^a   Ebbesen, F ^b   Brandt, J ^c   Dahl, M ^d   Esberg, G ^e   Eschen, C ^a   Grytter, C ^f   Kroner, J ^d   Norgaard M ^g   Reinholdt, J ^a   Stanchev, H ^h  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c Mental Health Center Glostrup   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f KOLDING HOSPITAL   (Denmark)

^g AALBORG UNIVERSITY HOSPITAL   (Denmark)

^h NAESTVED HOSPITAL   (Denmark)

Author keywords

Lamellar bodies; Lung surfactant; Prematurity; Respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT;

ARTICLE; BLOOD CELL COUNT; DISEASE SEVERITY; ELECTRON MICROSCOPY; FETUS LUNG MATURITY; GASTRIC SUCTION; GESTATIONAL AGE; HUMAN; LAMELLAR BODY; MAJOR CLINICAL STUDY; NEWBORN; PREDICTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SENSITIVITY AND SPECIFICITY;

BODY FLUIDS; CELL COUNT; HUMANS; INFANT, NEWBORN; MICROSCOPY, ELECTRON; ORGANELLES; PREDICTIVE VALUE OF TESTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; STOMACH;

EID: 78651364561     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.02010.x     Document Type: Article

References (29)

1. Soll RF,. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999; 4: CD001456.
2. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant for respiratory distress syndrome in newborns less than 30 weeks' gestation. Pediatrics 1999; 103: e24.
3. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. N Engl J Med 1991; 324: 865-71.
4. Egberts J, Brand R, Walti H, Bevilaqua G, Breart G, Gardini F,. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics 1997; 100: e4.
5. Buckingham S, Heinemann HO, Sommers SC, McNary WF,. Phospholipid synthesis in the large pulmonary alveolar cell: its relation to lung surfactant. Am J Pathol 1966; 48: 1027-41.
6. Buckingham S, Avery ME,. Time of appearance of lung surfactant in the foetal mouse. Natur 1962; 193: 688-9.
7. Williams MC,. Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs. J Cell Biol 1977; 72: 260-77.
8. Dubin SB,. Characterization of amniotic-fluid lamellar bodies by resistive-pulse counting-relationship to measures of fetal lung maturity. Clin Chim 1989; 35: 612-6.
9. Szallasi A, Gronowski AM, Eby CS,. Lamellar body count in amniotic fluid: a comparative study of four different hematology analyzers. Clin Chim 2003; 6: 994-7.
10. Grenache DG, Gronowski AM,. Fetal lung maturity. Clin Biochim 2006; 39: 1-10.
11. Wijnberger LDE, Huisjes AJM, Vorbij HAM, Franx A, Bruinse HW, Mol BWJ,. The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: a meta-analysis. Br J Obstet Gynecol 2001; 108: 583-8.
12. Piazze JJ, Maranghi L, Cerekja A, Meloni P, Gioia S, Fumian L, et al. Amniotic fluid lamellar body counts for the determination of fetal lung maturity: an update. J Perinat Med 2005; 33: 156-60.
13. Verder H, Ebbesen F, Linderholm B, Robertson B, Eschen C, Arrøe M, et al. Prediction of respiratory distress syndrome by the microbubble stability test on gastric aspirates in newborns of less than 32 weeks' gestation. Acta Paediatr 2003; 92: 728-33.
14. Daniel IWBS, Fiori HH, Piva JP, Munhoz TP, Nectoux AV, Fiori RM,. Lamellar body count and stable microbubble test on gastric aspirates from preterm infants for the diagnosis of respiratory distress syndrome. Neonatology 2010; 98: 150-5.
15. Benveniste D, Berg O, Pedersen JE,. A new technique for delivery of continuous positive airway pressure to the neonate. J Pediatr 1976; 88: 1015-9.
16. Moa G, Nilsson K, Zetterström H, Jonsson LO,. A new device for administration of nasal continuous positive airway pressure in the newborn: an experimental study. Crit Care Med 1988; 16: 1238-42.
17. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B,. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr 2009; 98: 1400-8.
18. Altman DG,. Practical statistics for medical research. London: Chapman and Hall, 1991.
19. Harboe M,. A method for determination of haemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 1959; 11: 66-70.
20. Rhodes PG, Hall RT,. Continuous positive airway pressure delivered by face mask in infants with idiopathic respiratory distress syndrome: a controlled study. Pediatrics 1973; 52: 17-21.
21. Dunn PM,. Respiratory distress syndrome. Continuous positive airway pressure (CPAP) using the Gregory box. Proc R Soc med 1984; 67: 245-7.
22. Bosma KJ, Lewis JF,. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome. Expert Opin Emerg Drugs 2007; 12: 461-77.
23. Stevens TP, Sinkin RA,. Surfactant replacement therapy. Chest 2007; 131: 1577-82.
24. Lewis JF, Velhuizen R,. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003; 65: 613-42.
25. Oulton M,. The role of centrifugation in the measurements of surfactant in amniotic fluid. Am J Obstet Gynecol 1979; 135: 337-43.
26. Pe'rez-Gil J,. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta 2008; 1778: 1676-95.
27. Verder H, Clausen J,. Assay of phospholipids in the amniotic fluid. Clin Chim Acta 1974; 51: 257-69.
28. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al. Prophylactic or early selective surfactant combined with NCPAP in very preterm infants. Pediatrics 2010; 125: e1402-9.
29. Ingimarsson J, Björklund L, Cursted T, Gudmunsson S, Larsson A, Robertson B, et al. Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs. Intensive Care Med 2004; 30: 1446-53.